Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B E Hillner

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Current Oncology Reports|August 8, 2001
Is cancer care best at high-volume providers?B E Hillner
Medical Section Proceedings : the ... Annual Meeting of the Medical Section of the American Council of Life Insurance. American Council of Life Insurance. Medical Section. Meeting|January 1, 1987
Basic principles of cost-effectiveness analysisB E Hillner
Southern Medical Journal|August 1, 1992
Estrogen therapy for geriatric osteoporosis: just one ball in a complex juggling actB E Hillner
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Cost-effectiveness assessment of interferon alfa-2b as adjuvant therapy of high-risk resected cutaneous melanomaB E Hillner
Pharmacoeconomics|December 9, 1995
Role of decision analysis in relation to clinical trials and a US perspective of the Battelle modelB E Hillner
Journal of the National Cancer Institute. Monographs|January 1, 1995
Potential evaluation of the incremental cost-effectiveness of paclitaxel in advanced non-small-cell lung cancer (Eastern Cooperative Oncology Group 5592)B E Hillner
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 1997
Decision analysis: MIBI imaging of nonpalpable breast abnormalitiesB E Hillner
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Financial costs, benefits, and patient risk preferences in node-negative breast cancer: insights from a decision analysis modelB E Hillner
Seminars in Oncology|September 7, 2001
Pharmacoeconomic issues in bisphosphonate treatment of metastatic bone diseaseB E Hillner
Seminars in Oncology|February 1, 1996
Economic and cost-effectiveness issues in breast cancer treatmentB E Hillner
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Current Oncology Reports|August 8, 2001
Is cancer care best at high-volume providers?B E Hillner
Medical Section Proceedings : the ... Annual Meeting of the Medical Section of the American Council of Life Insurance. American Council of Life Insurance. Medical Section. Meeting|January 1, 1987
Basic principles of cost-effectiveness analysisB E Hillner
Southern Medical Journal|August 1, 1992
Estrogen therapy for geriatric osteoporosis: just one ball in a complex juggling actB E Hillner
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Cost-effectiveness assessment of interferon alfa-2b as adjuvant therapy of high-risk resected cutaneous melanomaB E Hillner
Pharmacoeconomics|December 9, 1995
Role of decision analysis in relation to clinical trials and a US perspective of the Battelle modelB E Hillner
Journal of the National Cancer Institute. Monographs|January 1, 1995
Potential evaluation of the incremental cost-effectiveness of paclitaxel in advanced non-small-cell lung cancer (Eastern Cooperative Oncology Group 5592)B E Hillner
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 1997
Decision analysis: MIBI imaging of nonpalpable breast abnormalitiesB E Hillner
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Financial costs, benefits, and patient risk preferences in node-negative breast cancer: insights from a decision analysis modelB E Hillner
Seminars in Oncology|September 7, 2001
Pharmacoeconomic issues in bisphosphonate treatment of metastatic bone diseaseB E Hillner
Seminars in Oncology|February 1, 1996
Economic and cost-effectiveness issues in breast cancer treatmentB E Hillner
Pageof 8